首页 > 最新文献

Ceska a Slovenska Neurologie a Neurochirurgie最新文献

英文 中文
Correlation between self-esteem and self-compassion in patients with multiple sclerosis – a cross-sectional study 多发性硬化症患者自尊与自我同情的相关性——一项横断面研究
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-04-30 DOI: 10.48095/CCCSNN2021169
Hanieh Dahmardeh, Afsaneh Sadooghiasl, E. Mohammadi, A. Kazemnejad
{"title":"Correlation between self-esteem and self-compassion in patients with multiple sclerosis – a cross-sectional study","authors":"Hanieh Dahmardeh, Afsaneh Sadooghiasl, E. Mohammadi, A. Kazemnejad","doi":"10.48095/CCCSNN2021169","DOIUrl":"https://doi.org/10.48095/CCCSNN2021169","url":null,"abstract":"","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"27 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84158662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Iron deficiency anaemia in cerebral venous sinus thrombosis – cause or association? 缺铁性贫血伴脑静脉窦血栓形成——原因或关联?
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-04-30 DOI: 10.48095/CCCSNN2021208
Sinan Eliaçık, F. Tan
{"title":"Iron deficiency anaemia in cerebral venous sinus thrombosis – cause or association?","authors":"Sinan Eliaçık, F. Tan","doi":"10.48095/CCCSNN2021208","DOIUrl":"https://doi.org/10.48095/CCCSNN2021208","url":null,"abstract":"","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88092854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PPP2R5D-related intellectual disability and neurodevelopmental delay – the first case in the Czech Republic 与ppp2r5d相关的智力残疾和神经发育迟缓——捷克共和国的第一例
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-04-30 DOI: 10.48095/CCCSNN2021205
K. Slabá, Hana Pálová, P. Veselá, Štefánia Aulická, P. Konecná, M. Štěrba, P. Jabandžiev, O. Slabý, D. Prochazkova
{"title":"PPP2R5D-related intellectual disability and neurodevelopmental delay – the first case in the Czech Republic","authors":"K. Slabá, Hana Pálová, P. Veselá, Štefánia Aulická, P. Konecná, M. Štěrba, P. Jabandžiev, O. Slabý, D. Prochazkova","doi":"10.48095/CCCSNN2021205","DOIUrl":"https://doi.org/10.48095/CCCSNN2021205","url":null,"abstract":"","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"40 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81639352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual and digital analysis of the ultrasound image in a stable and progressive carotid atherosclerotic plaque 稳定和进展的颈动脉粥样硬化斑块的超声图像的视觉和数字分析
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-02-28 DOI: 10.48095/CCCSNN202138
D. Školoudík, Petra Kešnerová, T. Hrbáč, D. Netuka, J. Vomáčka, K. Langová, M. Roubec, R. Herzig, T. Belšán
{"title":"Visual and digital analysis of the ultrasound image in a stable and progressive carotid atherosclerotic plaque","authors":"D. Školoudík, Petra Kešnerová, T. Hrbáč, D. Netuka, J. Vomáčka, K. Langová, M. Roubec, R. Herzig, T. Belšán","doi":"10.48095/CCCSNN202138","DOIUrl":"https://doi.org/10.48095/CCCSNN202138","url":null,"abstract":"","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"24 1","pages":"38-44"},"PeriodicalIF":0.5,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72657779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Validation of the Czech version of the NPCS scale for the evaluation of the needs of patients with progressive neurological disease 捷克版NPCS量表用于评估进行性神经疾病患者需求的验证
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-02-28 DOI: 10.48095/CCCSNN202159
R. Bužgová, R. Kozáková
{"title":"Validation of the Czech version of the NPCS scale for the evaluation of the needs of patients with progressive neurological disease","authors":"R. Bužgová, R. Kozáková","doi":"10.48095/CCCSNN202159","DOIUrl":"https://doi.org/10.48095/CCCSNN202159","url":null,"abstract":"","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"3 1","pages":"59-65"},"PeriodicalIF":0.5,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72839384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Encephalocele in the Czech Republic – incidence, prenatal dia­gnostics and international comparison 捷克共和国的脑膨出——发病率、产前诊断和国际比较
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-02-28 DOI: 10.48095/CCCSNN202166
A. Sipek, V. Gregor, J. Klaschka, M. Malý, J. Jírová, N. Friedova
{"title":"Encephalocele in the Czech Republic – incidence, prenatal dia­gnostics and international comparison","authors":"A. Sipek, V. Gregor, J. Klaschka, M. Malý, J. Jírová, N. Friedova","doi":"10.48095/CCCSNN202166","DOIUrl":"https://doi.org/10.48095/CCCSNN202166","url":null,"abstract":"","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"19 1","pages":"66-70"},"PeriodicalIF":0.5,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77976137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Third ventricle bowing as a radiological marker of non-communicating hydrocephalus and successful endoscopic ventriculocisternostomy 第三脑室弯曲作为非交通性脑积水和成功的内窥镜脑室胸膜吻合的影像学标志
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-02-28 DOI: 10.48095/CCCSNN202181
T. Krejčí, O. Krejčí, M. Mruzek, Z. Večeřa, R. Lipina
{"title":"Third ventricle bowing as a radiological marker of non-communicating hydrocephalus and successful endoscopic ventriculocisternostomy","authors":"T. Krejčí, O. Krejčí, M. Mruzek, Z. Večeřa, R. Lipina","doi":"10.48095/CCCSNN202181","DOIUrl":"https://doi.org/10.48095/CCCSNN202181","url":null,"abstract":"","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"53 1","pages":"81-84"},"PeriodicalIF":0.5,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82319308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report of relapsing COVID-19 infection in a patient with multiple sclerosis treated with ocrelizumab 奥克雷单抗治疗多发性硬化症患者COVID-19感染复发1例报告
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-02-28 DOI: 10.48095/CCCSNN202192
J. Pazderková, H. Bartoš, P. Dlouhý, M. Vachová
{"title":"Case report of relapsing COVID-19 infection in a patient with multiple sclerosis treated with ocrelizumab","authors":"J. Pazderková, H. Bartoš, P. Dlouhý, M. Vachová","doi":"10.48095/CCCSNN202192","DOIUrl":"https://doi.org/10.48095/CCCSNN202192","url":null,"abstract":"","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"104 1","pages":"92-94"},"PeriodicalIF":0.5,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80536452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
" Influence of the first wave of COVID-19 pandemic on numbers of admitted ischemic stroke patients, on their dia­gnostics and therapy" 《第一波新冠肺炎疫情对缺血性脑卒中住院人数、诊断和治疗的影响》
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-02-28 DOI: 10.48095/CCCSNN202189
L. Jurák, V. Beneš, O. Bradáč, J. Dienelt, P. Suchomel
The first wave of COVID-19 pandemic has affected the lives of all of us in some way There was an assumption that at the time of the pandemic, there were lower numbers of hospitalized patients, not only with a diagnosis of ischemic stroke, because of people‘s fear of getting infected with COVID-19 virus in hospital facilities Moreover, there was a concern about the negative impact of the regimen measures on the diagnostics and treatment of patients with ischemic stroke We carried out a retrospective analysis of 191 patients admitted to our department with a diagnosis of ischemic stroke in a 3-month period of the first wave of COVID-19 pandemic from March to May 2020 and in a 3-month period from March to May 2019 The number of ischemic stroke patients hospitalized at Regional Hospital Liberec during the first wave of COVID-19 pandemic (3–5/2020) was slightly higher than during a comparable time a year ago (3–5/2019) Regarding the observed times of therapeutic procedures and the clinical outcome of patients with ischemic stroke, there were minimal, statistically non-significant, differences The first wave of COVID-19 pandemic affected neither the numbers of patients with ischemic stroke nor their diagnostics and therapy at Regional Hospital Liberec © 2021, Czech Medical Association J E Purkyne All rights reserved
第一波COVID-19大流行在某种程度上影响了我们所有人的生活。有一种假设认为,在大流行期间,住院患者人数较少,不仅是诊断为缺血性中风的患者,因为人们害怕在医院设施中感染COVID-19病毒。有负面影响的担忧的养生措施缺血性中风患者的诊断和治疗进行回顾性分析191例承认我们系的诊断缺血性中风在3个月时间内第一批COVID-19流行于2020年3月至5月,3个月期从2019年3月至5月缺血性中风患者的数量在地区医院住院期间利贝雷茨COVID-19的第一波在观察到的治疗程序次数和缺血性脑卒中患者的临床结果方面,差异很小,统计学上无显著差异。第一波COVID-19大流行既没有影响缺血性脑卒中患者的数量,也没有影响他们在利伯雷茨地区医院的诊断和治疗©2021,捷克医学协会J E Purkyne版权所有
{"title":"\" Influence of the first wave of COVID-19 pandemic on numbers of admitted ischemic stroke patients, on their dia­gnostics and therapy\"","authors":"L. Jurák, V. Beneš, O. Bradáč, J. Dienelt, P. Suchomel","doi":"10.48095/CCCSNN202189","DOIUrl":"https://doi.org/10.48095/CCCSNN202189","url":null,"abstract":"The first wave of COVID-19 pandemic has affected the lives of all of us in some way There was an assumption that at the time of the pandemic, there were lower numbers of hospitalized patients, not only with a diagnosis of ischemic stroke, because of people‘s fear of getting infected with COVID-19 virus in hospital facilities Moreover, there was a concern about the negative impact of the regimen measures on the diagnostics and treatment of patients with ischemic stroke We carried out a retrospective analysis of 191 patients admitted to our department with a diagnosis of ischemic stroke in a 3-month period of the first wave of COVID-19 pandemic from March to May 2020 and in a 3-month period from March to May 2019 The number of ischemic stroke patients hospitalized at Regional Hospital Liberec during the first wave of COVID-19 pandemic (3–5/2020) was slightly higher than during a comparable time a year ago (3–5/2019) Regarding the observed times of therapeutic procedures and the clinical outcome of patients with ischemic stroke, there were minimal, statistically non-significant, differences The first wave of COVID-19 pandemic affected neither the numbers of patients with ischemic stroke nor their diagnostics and therapy at Regional Hospital Liberec © 2021, Czech Medical Association J E Purkyne All rights reserved","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"11 1","pages":"89-91"},"PeriodicalIF":0.5,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84333515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The “new normal” for glioblastoma adjuvant treatment in a COVID-19 pandemic scenario COVID-19大流行情况下胶质母细胞瘤辅助治疗的“新常态
IF 0.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2021-02-28 DOI: 10.48095/CCCSNN202185
C. Mireștean, A. Crișan, C. Buzea, R. Iancu, D. Iancu
Multidisciplinary treatment of brain tumors has been severely affected by the COVID-19 pandemic In the context of a decrease in the number of neurosurgical interventions by over 50% in most centers from the countries affected by the pandemic, the setting of treatment priorities becomes essential Due to the poor prognosis and biological particularities related to rapid progression, grade IV malignant gliomas are a priority in treatment The severe limitations of hospitalization possibilities in intensive care units and the reduction of the possibilities of administration of adjuvant treatment leads to the necessity to take into account the possibilities for timely administration of adjuvant treatment in the decision for the neurosurgical treatment in new glioblastoma multiforme cases Multidisciplinary team evaluation of each case is mandatory in order to make a rational decision Isocitrate dehydrogenase (IDH) mutation and methylation status of O6-methylguanine-DNA methyl-transferase (MGMT) should be assessed as far as possible IDH wild-type status should be a decisive factor in prioritizing the treatment For young patients with a favorable performance status, the standard treatment includes long-course radiotherapy with concurrent temozolomide treatment, followed by 6-cycle adjuvant treatment with temozolomide, even in a COVID-19 pandemic scenario The optimal therapeutic choice in the case of elderly and/or frail patients includes a moderate hypofractionated radiotherapy regimen of 40 Gy in 15 daily fractions over 3 weeks, or a hypofractionated protocol with 25 Gy in 5 daily fractions, taking into account the age and Karnoffsky performance status Also, the MGMT methylation status must be taken into account for the decision to omit chemotherapy and for the delivery of a short-course radiotherapy regimen (25 Gy in 5 fractions) Omission of chemotherapy should consider both the additional risk of SARS-CoV-2 infection and the limited benefit of temozolomide treatment in the case of unmethylated MGMT status © 2021, Czech Medical Association J E Purkyne All rights reserved
在受新冠肺炎大流行影响的国家,大多数中心的神经外科干预数量减少了50%以上,由于预后差和与快速进展相关的生物学特性,确定治疗重点变得至关重要。IV级恶性胶质瘤优先治疗重症监护病房住院可能性的严重限制和给予辅助治疗的可能性的减少,导致在决定新发多形胶质母细胞瘤的神经外科治疗时,必须考虑及时给予辅助治疗的可能性,以便作出合理的多学科团队评估应尽可能评估异柠檬酸脱氢酶(IDH)突变和o6 -甲基鸟嘌呤- dna甲基转移酶(MGMT)甲基化状态IDH野生型状态应是优先治疗的决定性因素。对于表现状态良好的年轻患者,标准治疗包括长疗程放疗加替莫唑胺并发替莫唑胺6周期辅助治疗。即使在COVID-19大流行的情况下,老年人和/或体弱患者的最佳治疗选择包括在3周内15次每日40 Gy的中度低分割放疗方案,或在考虑年龄和Karnoffsky性能状态的情况下,5次每日25 Gy的低分割放疗方案。在决定是否省略化疗和实施短疗程放疗方案(25 Gy分5段)时,必须考虑MGMT甲基化状态。省略化疗应同时考虑SARS-CoV-2感染的额外风险和MGMT未甲基化情况下使用temozolomide治疗的有限益处©2021,捷克医学协会J E Purkyne版权所有
{"title":"The “new normal” for glioblastoma adjuvant treatment in a COVID-19 pandemic scenario","authors":"C. Mireștean, A. Crișan, C. Buzea, R. Iancu, D. Iancu","doi":"10.48095/CCCSNN202185","DOIUrl":"https://doi.org/10.48095/CCCSNN202185","url":null,"abstract":"Multidisciplinary treatment of brain tumors has been severely affected by the COVID-19 pandemic In the context of a decrease in the number of neurosurgical interventions by over 50% in most centers from the countries affected by the pandemic, the setting of treatment priorities becomes essential Due to the poor prognosis and biological particularities related to rapid progression, grade IV malignant gliomas are a priority in treatment The severe limitations of hospitalization possibilities in intensive care units and the reduction of the possibilities of administration of adjuvant treatment leads to the necessity to take into account the possibilities for timely administration of adjuvant treatment in the decision for the neurosurgical treatment in new glioblastoma multiforme cases Multidisciplinary team evaluation of each case is mandatory in order to make a rational decision Isocitrate dehydrogenase (IDH) mutation and methylation status of O6-methylguanine-DNA methyl-transferase (MGMT) should be assessed as far as possible IDH wild-type status should be a decisive factor in prioritizing the treatment For young patients with a favorable performance status, the standard treatment includes long-course radiotherapy with concurrent temozolomide treatment, followed by 6-cycle adjuvant treatment with temozolomide, even in a COVID-19 pandemic scenario The optimal therapeutic choice in the case of elderly and/or frail patients includes a moderate hypofractionated radiotherapy regimen of 40 Gy in 15 daily fractions over 3 weeks, or a hypofractionated protocol with 25 Gy in 5 daily fractions, taking into account the age and Karnoffsky performance status Also, the MGMT methylation status must be taken into account for the decision to omit chemotherapy and for the delivery of a short-course radiotherapy regimen (25 Gy in 5 fractions) Omission of chemotherapy should consider both the additional risk of SARS-CoV-2 infection and the limited benefit of temozolomide treatment in the case of unmethylated MGMT status © 2021, Czech Medical Association J E Purkyne All rights reserved","PeriodicalId":50704,"journal":{"name":"Ceska a Slovenska Neurologie a Neurochirurgie","volume":"32 1","pages":"85-88"},"PeriodicalIF":0.5,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82410789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ceska a Slovenska Neurologie a Neurochirurgie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1